|
|
||||||||
Benaroya Research Institute at Virginia Mason, Seattle, WA 98101
The memory T cell response is polyclonal, with the magnitude and specificity of the response controlled in part by the burst size of T cells expanded from effector/memory precursors. Sensitive assays using HLA class II multimers were used to detect low-frequency Ag-specific T cells directed against influenza viral Ags in subjects immunized with the influenza vaccine. Direct ex vivo tetramer staining of PBMC from five individuals identified frequencies of hemagglutinin (HA) 306318 tetramer binding CD4+ T cells in the peripheral blood ranging from 1 in 600 to 1 in 30,000 CD4+ T cells. These frequencies were validated by counting CFSElow, tetramer-positive T cells after in vitro expansion. Low frequency of T cells directed to other influenza epitopes, including DRA1*0101/DRB1*0401-restricted matrix protein 6073, DRA1*0101/DRB1*0101-restricted matrix protein 1829, DRA1*0101/DRB1*0701-restricted HA 232244 and DRA1*0101/DRB1*0101-restricted nucleoprotein 206217 were also determined. T cells which occurred at a frequency as low as 1 in 350,000 could be ascertained by in vitro expansion of precursors. Peripheral HA306318-responsive T cells expanded 2- to 5-fold following influenza vaccination. Examination of phenotypic markers of the HA306318-responsive T cells in the peripheral blood indicated that the majority were CD45RA-, CD27+, CD25-, CD28+, and CD62L-, while T cell clones derived from this population were CD45RA-, CD27-, CD25+, CD28+, and CD62L-.
This article has been cited by other articles:
![]() |
W. W. Kwok, J. Yang, E. James, J. Bui, L. Huston, A. R. Wiesen, and M. Roti The Anthrax Vaccine Adsorbed Vaccine Generates Protective Antigen (PA)-Specific CD4+ T Cells with a Phenotype Distinct from That of Naive PA T Cells Infect. Immun., October 1, 2008; 76(10): 4538 - 4545. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Roti, J. Yang, D. Berger, L. Huston, E. A. James, and W. W. Kwok Healthy Human Subjects Have CD4+ T Cells Directed against H5N1 Influenza Virus J. Immunol., February 1, 2008; 180(3): 1758 - 1768. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. James, J. Bui, D. Berger, L. Huston, M. Roti, and W. W. Kwok Tetramer-guided epitope mapping reveals broad, individualized repertoires of tetanus toxin-specific CD4+ T cells and suggests HLA-based differences in epitope recognition Int. Immunol., November 1, 2007; 19(11): 1291 - 1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Barbey, E. Pradervand, N. Barbier, and F. Spertini Ex Vivo Monitoring of Antigen-Specific CD4+ T Cells after Recall Immunization with Tetanus Toxoid Clin. Vaccine Immunol., September 1, 2007; 14(9): 1108 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mitra-Kaushik, J. Cruz, L. J. Stern, F. A. Ennis, and M. Terajima Human Cytotoxic CD4+ T Cells Recognize HLA-DR1-Restricted Epitopes on Vaccinia Virus Proteins A24R and D1R Conserved among Poxviruses J. Immunol., July 15, 2007; 179(2): 1303 - 1312. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Li, N. Wang, D. Zhou, C. S. K. Yee, C.-H. Chang, R. R. Brutkiewicz, and J. S. Blum Disruption of MHC Class II-Restricted Antigen Presentation by Vaccinia Virus J. Immunol., November 15, 2005; 175(10): 6481 - 6488. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Latham, K. B. Whittington, R. Zhou, Z. Qian, and E. F. Rosloniec Ex Vivo Characterization of the Autoimmune T Cell Response in the HLA-DR1 Mouse Model of Collagen-Induced Arthritis Reveals Long-Term Activation of Type II Collagen-Specific Cells and Their Presence in Arthritic Joints J. Immunol., April 1, 2005; 174(7): 3978 - 3985. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Reid, T. G. Fanning, T. A. Janczewski, R. M. Lourens, and J. K. Taubenberger Novel Origin of the 1918 Pandemic Influenza Virus Nucleoprotein Gene J. Virol., November 15, 2004; 78(22): 12462 - 12470. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wong, R. Lau, J. Chang, T. Kuus-Reichel, V. Brichard, C. Bruck, and J. Weber Immune Responses to a Class II Helper Peptide Epitope in Patients with Stage III/IV Resected Melanoma Clin. Cancer Res., August 1, 2004; 10(15): 5004 - 5013. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lucas, C. L. Day, J. R. Wyer, S. L. Cunliffe, A. Loughry, A. J. McMichael, and P. Klenerman Ex Vivo Phenotype and Frequency of Influenza Virus-Specific CD4 Memory T Cells J. Virol., July 1, 2004; 78(13): 7284 - 7287. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-A. Younes, B. Yassine-Diab, A. R. Dumont, M.-R. Boulassel, Z. Grossman, J.-P. Routy, and R.-P. Sekaly HIV-1 Viremia Prevents the Establishment of Interleukin 2-producing HIV-specific Memory CD4+ T Cells Endowed with Proliferative Capacity J. Exp. Med., December 15, 2003; 198(12): 1909 - 1922. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |